Cbre 2025 Life Sciences Outlook. Sector Outlook & Investment Implication CBRE Life sciences lab and R&D property sales dropped to their lowest level in more than a decade in 2024, primarily due to high interest rates and weak supply-and-demand fundamentals, according to CBRE However, improving macroeconomic conditions, increased demand, and lower interest rates could lead to greater investment sales activity in 2025.
Life Sciences CBRE from www.cbre.com
The ongoing demand for Life Sciences laboratory space will continue to outstrip supply, yet relief is on the horizon as more projects near completion and enter the market. A surge of new lab/R&D supply will be the life sciences market's biggest challenge in the first half of 2025 before tapering off later in the year
Life Sciences CBRE
Life Sciences Outlook highlights continued growth driven by key factors such as an improving economy, robust sector employment, and a more favorable capital market environment employment reached record growth, and the industry remains "in a period of unprecedented innovation and discovery," according to CBRE's "U.S Life sciences lab and R&D property sales dropped to their lowest level in more than a decade in 2024, primarily due to high interest rates and weak supply-and-demand fundamentals, according to CBRE
Sector Outlook & Investment Implication CBRE. Find a Property Find a Property CBRE are global leaders in commercial property, both to rent and for sale. According to this report, CBRE expects many of these same factors that benefited the sector in Q4 to contribute to the.
Phoenix metro growing fast as a life sciences research hub, CBRE report finds Phoenix Business. Life Sciences Outlook provides investors and occupiers alike with valuable insights to where the market is headed this year. Various drivers of life sciences industry expansion appear well entrenched, acting as a.